BLCO News and Press, Bausch + Lomb Corporation

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the first event in an R&D “Teach-in” webinar series that will provide deeper insights on the company’s differentiated pro...

2026-03-04 09:35:44 ET Health Care ETFs: ( XLV ), ( VHT ), ( IHI ), ( IXJ ), ( IYH ), ( FHLC ), ( XPH ), ( PPH ...

2026-02-28 14:16:27 ET More on FedEx, EssilorLuxottica ADR FedEx Corporation (FDX) Analyst/Investor Day Transcript EssilorLuxottica: Turning Positive On Market-Share Gain (Rating Upgrade) FedEx Investor Day: Strong Run, Weak Catalyst (Rating Downgrade) FedEx ...

Global review highlights increasing prevalence of noninfectious ocular redness due to digital eye strain, dry eye disease, allergies and environmental exposures LUMIFY redness reliever eye drops (brimonidine tartrate 0.025%) are highlighted as a differentiated OTC option due to its highly sel...

2026-02-19 14:54:45 ET Investment Overview Bausch + Lomb Corporation ( BLCO ), a leading global eye health specialist and marketer and seller of ~400 products in total (source: Q3 2025 10-Q filing ), announced its Q4 and full-year earnings on February 18th.... Read...

2026-02-19 10:07:31 ET Last October 2025, Bausch Health Companies Inc. ( BHC ) jumped by 1% after it posted third quarter results . This time, the fourth-quarter bottom line missed expectations. Both its revenue for Q4 and revenue guidance for 2026 exceeded consensus. However, t...

2026-02-18 12:56:09 ET More on Bausch + Lomb Bausch + Lomb Corporation (BLCO) Q4 2025 Earnings Call Transcript Bausch + Lomb Corporation 2025 Q4 - Results - Earnings Call Presentation Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Con...

2026-02-18 12:55:09 ET Bausch + Lomb Corporation (BLCO) Q4 2025 Earnings Call February 18, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Bausch + Lomb Corporation (BLCO) Q4 2025 Earnings Call Transcript

2026-02-18 07:01:55 ET More on Bausch + Lomb Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Bausch + Lomb: I ...

Delivered meaningful EBITDA margin expansion and operating leverage in the fourth quarter Fourth-Quarter 2025 Financial Results Revenue of $1.405 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $58 Million Adjusted EBITDA (non-GAAP) 1 of $3...